Lecrux Clotilde, McCabe Christopher, Weir Christopher J, Gallagher Lindsay, Mullin Jim, Touzani Omar, Muir Keith W, Lees Kennedy R, Macrae I Mhairi
7TMRI Facility, Division of Clinical Neuroscience, University of Glasgow, Garscube Estate, Glasgow G61 1QH, UK.
Stroke. 2008 Feb;39(2):448-54. doi: 10.1161/STROKEAHA.107.492934. Epub 2008 Jan 3.
The study aim was to assess the effects of magnesium sulfate (MgSO(4)) administration on white matter damage in vivo in spontaneously hypertensive rats.
The left internal capsule was lesioned by a local injection of endothelin-1 (ET-1; 200 pmol) in adult spontaneously hypertensive rats. MgSO(4) was administered (300 mg/kg SC) 30 minutes before injection of ET-1, plus 200 mg/kg every hour thereafter for 4 hours. Infarct size was measured by T2-weighted magnetic resonance imaging (day 2) and histology (day 11), and functional recovery was assessed on days 3 and 10 by the cylinder and walking-ladder tests.
ET-1 application induced a small, localized lesion within the internal capsule. Despite reducing blood pressure, MgSO(4) did not significantly influence infarct volume (by magnetic resonance imaging: median, 2.1 mm(3); interquartile range, 1.3 to 3.8, vs 1.6 mm(3) and 1.2 to 2.1, for the vehicle-treated group; by histology: 0.3 mm(3) and 0.2 to 0.9 vs 0.3 mm(3) and 0.2 to 0.5, respectively). Significant forelimb and hindlimb motor deficits were evident in the vehicle-treated group as late as day 10. These impairments were significantly ameliorated by MgSO(4) in both cylinder (left forelimb use, P<0.01 and both-forelimb use, P<0.03 vs vehicle) and walking-ladder (right hindlimb score, P<0.02 vs vehicle) tests.
ET-1-induced internal capsule ischemia in spontaneously hypertensive rats represents a good model of lacunar infarct with small lesion size, minimal adverse effects, and a measurable motor deficit. Despite inducing mild hypotension, MgSO(4) did not significantly influence infarct size but reduced motor deficits, supporting its potential utility for the treatment of lacunar infarct.
本研究旨在评估硫酸镁(MgSO₄)给药对自发性高血压大鼠体内白质损伤的影响。
在成年自发性高血压大鼠中,通过局部注射内皮素-1(ET-1;200 pmol)损伤左侧内囊。在注射ET-1前30分钟给予MgSO₄(300 mg/kg皮下注射),此后每小时给予200 mg/kg,共4小时。在第2天通过T2加权磁共振成像和第11天通过组织学测量梗死灶大小,并在第3天和第10天通过圆筒试验和走梯试验评估功能恢复情况。
应用ET-1在内囊内诱导出一个小的局限性病变。尽管硫酸镁可降低血压,但对梗死灶体积无显著影响(通过磁共振成像:中位数,2.1 mm³;四分位间距,1.3至3.8,而 Vehicle 治疗组为1.6 mm³和1.2至2.1;通过组织学:分别为0.3 mm³和0.2至0.9与0.3 mm³和0.2至0.5)。在 Vehicle 治疗组中,直至第10天仍有明显的前肢和后肢运动功能障碍。在圆筒试验(左前肢使用,P<0.01;双前肢使用,P<0.03 vs Vehicle)和走梯试验(右后肢评分,P<0.02 vs Vehicle)中,硫酸镁均显著改善了这些损伤。
ET-1诱导的自发性高血压大鼠内囊缺血是腔隙性梗死的良好模型,病变小、不良反应小且运动功能障碍可测量。尽管硫酸镁可引起轻度低血压,但对梗死灶大小无显著影响,但可减轻运动功能障碍,支持其在腔隙性梗死治疗中的潜在应用价值。